首页> 外文会议>Society for Biomaterials annual meeting and exposition >Specificity of Adsorption in a Prototype Whole Blood Affinity Therapy Device for Removal of Staphylococcus aureus
【24h】

Specificity of Adsorption in a Prototype Whole Blood Affinity Therapy Device for Removal of Staphylococcus aureus

机译:原型全血亲和力治疗设备中去除金黄色葡萄球菌的吸附特异性。

获取原文

摘要

Bacterial removal by the anti-thrombogenic heparin media was much greater for MRSA, which binds to soluble heparin, relative to P. aeruginosa which does not. The (thrombogenic) control media also bound some MRSA non-specifically. A very long list of pathogens and toxins have been reported to bind to soluble heparin and heparan sulfate. This indicates a.) the breadth of adsorbates that may be removed from whole blood by 'immobilized heparin affinity therapy' and b.) its potential utility as a clinical treatment for bacteremia, particularly when caused by drug-resistant organisms, or when no alternative treatments are available.
机译:相对于铜绿假单胞菌而言,抗血栓形成的肝素培养基对MRSA的细菌去除作用要大得多,MRSA与可溶性肝素结合。 (血栓形成)控制介质还非特异性地结合了一些MRSA。据报道,很长的病原体和毒素与可溶性肝素和硫酸乙酰肝素结合。这表明a。)可以通过“固定化肝素亲和疗法”从全血中去除的吸附物的广度,以及b。)其作为临床菌血症治疗的潜在效用,尤其是在由耐药菌引起的情况下,或者在无替代方法的情况下治疗是可用的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号